![Mark Bonyhadi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bonyhadi
Plus aucun poste en cours
Profil
Mark L.
Bonyhadi served as the Chairman of the American Society of Gene & Cell Therapy.
He was the Director-Global Business Development at Life Technologies Ltd. from 2006 to 2013.
Dr. Bonyhadi also worked as an Independent Director at TC Biopharm (Holdings) Plc from 2022 to 2024.
Prior to that, he was the Vice President-Research & Development at Xcyte Therapies, Inc. from 1997 to 2006.
From 2013 to 2018, he held the position of Vice President-Research & Head-Academic Affairs at Juno Therapeutics, Inc. Dr. Bonyhadi was also a Senior Scientist at Systemix, Inc. He served as a Senior Advisor at Qiming US Ventures Management, LLC from 2018 to 2022.
Dr. Bonyhadi obtained his undergraduate degree from The Reed Institute in 1982 and his doctorate degree from the University of California, Berkeley in 1990.
Anciens postes connus de Mark Bonyhadi
| Sociétés | Poste | Fin |
|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Directeur/Membre du Conseil | 26/06/2024 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Consultant / Advisor | 31/12/2022 |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Directeur Technique/Scientifique/R&D | 12/10/2021 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/01/2018 |
Life Technologies Ltd.
 Life Technologies Ltd. BiotechnologyHealth Technology Operates as a global biotechnology tools company | Corporate Officer/Principal | 01/01/2013 |
Formation de Mark Bonyhadi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Xcyte Therapies, Inc.
 Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
The Reed Institute
 The Reed Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Operates as a global biotechnology tools company | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
TC Biopharm (Holdings) Plc
 TC Biopharm (Holdings) Plc BiotechnologyHealth Technology Operates as a holding company through it's subsidiaries develops clinical-stage cell therapies | Health Technology |
